Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about cbdMD, Inc.
cbdMD, Inc. News
cbdMD, Inc. Quantitative Score
About cbdMD, Inc.
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.
cbdMD, Inc. Earnings & Revenue
cbdMD, Inc. Financials
Table Compare
Compare YCBD metrics with: | |||
|---|---|---|---|
Earnings & Growth | YCBD | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | YCBD | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | YCBD | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | YCBD | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
cbdMD, Inc. Income
cbdMD, Inc. Balance Sheet
cbdMD, Inc. Cash Flow
cbdMD, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Sell |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Buy |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
cbdMD, Inc. Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
cbdMD, Inc. Executives
| Name | Role |
|---|---|
| Mr. T. Ronan Kennedy | Interim Chief Executive Officer, Chief Financial Officer & Principal Executive Officer |
| Mr. Francisco Mangual | Senior Vice President of Sales |
| Dr. Sibyl Swift Ph.D. | CSO, Vice President of Regulatory Affairs & Director |
| Robert Pettway | Director of Public Relations |
| Ms. Shannon Charles | Chief Marketing Officer |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. T. Ronan Kennedy | Interim Chief Executive Officer, Chief Financial Officer & Principal Executive Officer | Male | 1980 | 275K |
| Mr. Francisco Mangual | Senior Vice President of Sales | Male | 1979 | -- |
| Dr. Sibyl Swift Ph.D. | CSO, Vice President of Regulatory Affairs & Director | 1981 | -- | |
| Robert Pettway | Director of Public Relations | -- | ||
| Ms. Shannon Charles | Chief Marketing Officer | Female | -- |
cbdMD, Inc. Insider Trades
| Date | 26 Sep |
| Name | Kennedy Thomas Ronan |
| Role | CEO and CFO |
| Transaction | Acquired |
| Type | P-Purchase |
| Shares | 1000 |
| Date | 23 Sep |
| Name | Kennedy Thomas Ronan |
| Role | CEO and CFO |
| Transaction | Acquired |
| Type | P-Purchase |
| Shares | 38465 |
| Date | 23 Aug |
| Name | Raines William F III |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 75000 |
| Date | 29 Mar |
| Name | Whitford Bradley Nelson |
| Role | Chief Accounting Officer |
| Transaction | Disposed |
| Type | |
| Shares | 0 |
| Date | 27 Jan |
| Name | Whitford Bradley Nelson |
| Role | Chief Accounting Officer |
| Transaction | Disposed |
| Type | |
| Shares | 334 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 26 Sep | Kennedy Thomas Ronan | CEO and CFO | Acquired | P-Purchase | 1000 |
| 23 Sep | Kennedy Thomas Ronan | CEO and CFO | Acquired | P-Purchase | 38465 |
| 23 Aug | Raines William F III | Director | Acquired | A-Award | 75000 |
| 29 Mar | Whitford Bradley Nelson | Chief Accounting Officer | Disposed | 0 | |
| 27 Jan | Whitford Bradley Nelson | Chief Accounting Officer | Disposed | 334 |